A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil–epirubicine–cyclophosphamide (FEC100) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000)
Titel:
A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil–epirubicine–cyclophosphamide (FEC100) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000)
Auteur:
Delbaldo, C. Serin, D. Mousseau, M. Greget, S. Audhuy, B. Priou, F. Berdah, J.F. Teissier, E. Laplaige, P. Zelek, L. Quinaux, E. Buyse, M. Piedbois, P.